Prevention of development of carriers in typhoid and paratyphoid fever.
D000293:Adolescent; D000328:Adult; D000372:Agglutination Tests; D000373:Agglutinins / Q000032:analysis; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000032:analysis; D000917:Antibody Formation; D001770:Blood Bactericidal Activity; D002353:Carrier State / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D051379:Mice; D008875:Middle Aged; D010284:Paratyphoid Fever / Q000276:immunology / Q000517:prevention & control*; D012008:Recurrence; D012737:Sex Factors; D014435:Typhoid Fever / Q000276:immunology / Q000517:prevention & control*; D014436:Typhoid-Paratyphoid Vaccines / Q000008:administration & dosage
D000373:Agglutinins; D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D014436:Typhoid-Paratyphoid Vaccines